Genomic alterations and RNA/protein expression profiling

This working platform includes different European groups with complementary areas of expertise and activities. In previous joint studies we have identified the primary genetic alterations, cell cycle deregulation mechanisms, and secondary genetic alterations in MCL. These investigations have led to the identification of several molecular alterations that play a crucial role in the pathogenesis of MCL.

In future projects our efforts will be devoted to translate the information generated by global genomic and proteomic studies into the clinical practice by further characterizing the involved molecular signal pathways and explore new potential targets for molecular therapeutic approaches.

 
Corporate Partners - Individual Sponsors
Sat, 03rd October 2020 to Mon, 05rd October 2020
7th Immunotherapy of Cancer Conference
ITOC7
more dates
Tue, 23rd June 2020
The 1st Czernecki Donnelly Prize was awarded to Elisabeth Silkenstedt
more news